Mycoplasma hyopneumoniae (Mhp) is a leading cause of respiratory disease throughout the swine industry. Controlling Mhp infection within the entire production chain provides optimum results.  

The role of Mhp vaccines is to stimulate an active immune response and help reduce Mhp associated lung lesions and clinical disease.  

Ingelvac MycoFLEX^® has been proven to reduce lung lesions and pneumonia associated with Mhp infection. A recent study showed piglets had a reduction in colonization compared to non-vaccinates.¹ 

• Timing of vaccination  
  Single-dose, 1-mL vaccination can be given to pigs 3 weeks of age or older to best fit your program.  

• Long duration of immunity  
  Ingelvac MycoFLEX^®  provides at least 26 weeks of immunity to last through market.  

• Rapid onset of immunity with fewer reactions  
  Contains the innovative ImpranFLEX^® adjuvant technology, which provides rapid onset of immunity as well as a low risk of adverse reactions in pigs.  

Single-dose, 1-mL vaccination can be given to pigs 3 weeks of age or older to best fit your program.  

INGELVAC MYCOFLEX is a non-viscous, highly syringeable, one-dose, 1-mL mycoplasma vaccine that aids in the reduction of enzootic pneumonia caused by Mhp when administered to pigs 3 weeks of age or older. It also contains the unique ImpranFLEX^® water-based polymer adjuvant, which improves the immune response in pigs.  

INGELVAC MYCOFLEX Safety Data Sheet (SDS)

• Store in dark at 35–45ºF (2–7°C). Do not freeze. Use entire contents when first opened. In case of anaphylactic reaction, epinephrine is symptomatic treatment. Do not vaccinate within 21 days before slaughter.